METROPOLITAN LIFE INSURANCE CO/NY - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 137 filers reported holding CARA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$7,050
+13.0%
2,491
+96.0%
0.00%
Q1 2023$6,241
-80.6%
1,271
-57.5%
0.00%
-100.0%
Q4 2022$32,091
+14.7%
2,9880.0%0.00%0.0%
Q3 2022$27,968
+2.5%
2,9880.0%0.00%0.0%
Q2 2022$27,280
-24.9%
2,9880.0%0.00%0.0%
Q1 2022$36,304
-75.5%
2,988
-75.4%
0.00%
-50.0%
Q4 2021$147,938
-28.1%
12,146
-8.9%
0.00%
-33.3%
Q3 2021$205,887
+8.3%
13,3260.0%0.00%0.0%
Q2 2021$190,162
-31.8%
13,326
+3.7%
0.00%
-25.0%
Q1 2021$278,887
+43.5%
12,8460.0%0.00%
+33.3%
Q4 2020$194,360
+18.9%
12,8460.0%0.00%0.0%
Q3 2020$163,465
-25.6%
12,8460.0%0.00%
-25.0%
Q2 2020$219,667
+29.4%
12,8460.0%0.00%0.0%
Q1 2020$169,696
-14.7%
12,846
+4.0%
0.00%
+33.3%
Q4 2019$198,975
-17.7%
12,351
-6.6%
0.00%
-25.0%
Q3 2019$241,662
-1.2%
13,220
+16.2%
0.00%0.0%
Q2 2019$244,541
+9.6%
11,3740.0%0.00%0.0%
Q1 2019$223,158
+50.9%
11,3740.0%0.00%
+33.3%
Q4 2018$147,862
-99.9%
11,374
+31.0%
0.00%0.0%
Q2 2018$166,318,000
+54.7%
8,6850.0%0.00%
+50.0%
Q1 2018$107,521,000
+101334.9%
8,6850.0%0.00%
+100.0%
Q4 2017$106,000
-53.3%
8,685
-47.6%
0.00%0.0%
Q3 2017$227,000
-11.0%
16,5690.0%0.00%
-50.0%
Q2 2017$255,000
-16.4%
16,5690.0%0.00%0.0%
Q1 2017$305,000
+35.6%
16,569
+23.9%
0.00%0.0%
Q4 2015$225,000
+26.4%
13,370
+7.4%
0.00%
+100.0%
Q3 2015$178,00012,4450.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders